Posted by Michael Wonder on 01 Feb 2020
PBS listing for cystic fibrosis drug an 'absolute game changer'
31 January 2020 - Three drugs have been added to the Pharmaceutical Benefits Scheme, saving some patients up to $250,000 a year.
The PBS listing for cystic fibrosis drug Symdeko has been extended so the 10 to 15 Australians living with an ultra-rare cystic fibrosis gene mutation will now be able to access it without having to pay hundreds of thousands of dollars.
Adam Simeoni said the new cystic fibrosis drugs have "changed my life for the better".
